National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

lexatumumab (lek-suh-TOO-moo-mab)

 A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. Lexatumumab is a type of monoclonal antibody. Also called HGS-ETR2.



Previous Definitions:levofloxacin, levonorgestrel, Levulan, Levulan Kerastick, Lexapro
Next Definitions:LGD1069, LH-RH, LH-RH agonist, Lhermitte's sign, Li-Fraumeni syndrome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov